Researchers at Chiba University have developed a nanopore sequencing workflow that identifies fungal species in blood culture samples within about seven hours, before cultures turn positive, potentially enabling earlier targeted antifungal treatment.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.